Intranasal Administration of IL-27 Ameliorates Nasal Allergic Responses and Symptoms

Conclusions: This study showed, for the first time, that intranasal administration of IL-27 inhibited nasal allergic responses and symptoms even after the establishment of allergic rhinitis and suggested that IL-27 is useful as an intranasal therapeutic agent.Int Arch Allergy Immunol (Source: International Archives of Allergy and Immunology)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2qLOHzf